EVANS CITY, Pa., March 14, 2017 /PRNewswire/ -- Today we are proud to announce the creation of Callery,
Callery's current product portfolio includes a range of Specialty Alkoxide bases & Borane derivatives, as well as a variety of custom products based on the company's core competency in the handling of highly reactive compounds. Callery's world-class facility includes R&D labs, pilot plant, large scale production facilities and all knowledge associated with existing and developmental products.
Bob Girton, member of Callery's Board of Directors, said: "We are grateful for all of the hard work by the transition team over the last several months for helping us carve out the Callery business from BASF with minimal impact on our customers. We are excited to join them in taking Callery to its next level of success and build on the business' commitment to environmental health and safety, a high level of product quality, and industry leading reagent and organometallic technology."
The company's products have enabled some of the world's most impressive innovations, including billion-dollar blockbuster drugs, agro chemicals, and other high performance products from electronics to polymer applications.
Soon, Callery will be announcing its new management team to lead the company on its growth path in the coming years. The company is committed to the continued delivery of innovative products that enable customer success.
About CalleryCallery, formerly BASF's Inorganic Specialties Business, is the world's leading expert in alkoxide bases, borane derivatives, and other highly reactive chemistries. Headquartered in Evans City, Pennsylvania, Callery prides itself in enabling its customers' success with world-class innovators, unmatched quality, flexible production options, outstanding customer service, and global supply chain management. Callery's products enable some of the world's most successful innovations from billion-dollar blockbuster drugs to next-generation OLEDs. How can Callery's capabilities enable your next big innovation? Further information at www.callery.com.
PR Contact: Andy Fritts, CEO, FH Group, firstname.lastname@example.org, 814-459-2443
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/basf-inorganic-specialties-divestiture-creates-new-business-named-callery-300423281.html
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All